Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Ippolito, Danielle L ^a   James, Wesley A ^a   Tinnemore, Deborah ^a   Huang, Raywin R ^a   Dehart, Mary J ^a   Williams, Julie ^a   Wingerd, Mark A ^a   Demons, Samandra T ^a  

^a Madigan Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHY; GROUP B STREPTOCOCCAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SEROPREVALENCE; SEROTYPE; STREPTOCOCCUS AGALACTIAE; TERTIARY HEALTH CARE; UNITED STATES; ADOLESCENT; CLASSIFICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVALENCE; PUBLIC HOSPITAL; SEROTYPING; STATISTICS; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; CANADA; FEMALE; HOSPITALS, MILITARY; HUMANS; NORTHWESTERN UNITED STATES; PREVALENCE; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 78549284936     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-336     Document Type: Article

References (84)

1. Schrag S, Gorwitz R, Fulz-Butts K, Schuchat A. Prevention of perinatal Group B Streptococcal disease. MMWR 2002, 51:1-22. Center for Disease Control.
2. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998, 11(3):497-513. 88893, 9665980.
3. Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000, 21(7):473-483. 10.1086/501791, 10926399.
4. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ, . Active Bacterial Core Surveillance/Emerging Infections Program Network Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299(17):2056-2065. 10.1001/jama.299.17.2056, 18460666, Active Bacterial Core Surveillance/Emerging Infections Program Network.
5. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a Proposed New Streptococcus agalactiae Serotype. J Clin Microbiol 2007, 45(9):2929-2936. 10.1128/JCM.00117-07, 2045254, 17634306.
6. Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, Rappuoli R. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006, 4(12):932-942. 10.1038/nrmicro1552, 2742968, 17088932.
7. Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods 2010, 80(2):212-214. 10.1016/j.mimet.2009.11.010, 19958797.
8. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009, 360(25):2626-2636. 10.1056/NEJMoa0806820, 19535801.
9. Manning SD, Lacher DW, Davies HD, Foxman B, Whittam TS. DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J Clin Microbiol 2005, 43(12):6113-6116. 10.1128/JCM.43.12.6113-6116.2005, 1317180, 16333106.
10. Poyart C, Tazi A, Reglier-Poupet H, Billoet A, Tavares N, Raymond J, Trieu-Cuot P. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007, 45(6):1985-1988. 10.1128/JCM.00159-07, 1933079, 17376884.
11. Whitney CG, Daly S, Limpongsanurak S, Festin MR, Thinn KK, Chipato T, Lumbiganon P, Sauvarin J, Andrews W, Tolosa JE. The international infections in pregnancy study: group B streptococcal colonization in pregnant women. J Matern Fetal Neonatal Med 2004, 15(4):267-274. 10.1080/14767050410001668617, 15280136.
12. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Baker CJ, Marrs CF. Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol 2004, 42(1):146-150. 10.1128/JCM.42.1.146-150.2004, 321726, 14715745.
13. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 2000, 96(4):498-503. 10.1016/S0029-7844(00)00977-7, 11004347.
14. Croak A, Abate G, Goodrum K, Modrzakowski M. Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio. Am J Obstet Gynecol 2003, 188(5):1148-1150. 10.1067/mob.2003.293, 12748459.
15. Davies HD, Adair C, McGeer A, Ma D, Robertson S, Mucenski M, Kowalsky L, Tyrell G, Baker CJ. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis 2001, 184(3):285-291. 10.1086/322029, 11443553.
16. Ferrieri P, Baker CJ, Hillier SL, Flores AE. Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates. Indian J Med Res 2004, 119(Suppl):191-196.
17. Ferrieri P, Cleary PP, Seeds AE. Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants. J Med Microbiol 1977, 10(1):103-114. 10.1099/00222615-10-1-103, 320335.
18. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999, 104(2 Pt 1):203-209. 10.1542/peds.104.2.203, 10428995.
19. Manning SD. Molecular epidemiology of Streptococcus agalactiae (group B Streptococcus). Front Biosci 2003, 8:s1-18. 10.2741/985, 12456367.
20. Manning SD, Ki M, Marrs CF, Kugeler KJ, Borchardt SM, Baker CJ, Foxman B. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis 2006, 6:116. 10.1186/1471-2334-6-116, 1559624, 16846499.
21. McKenna DS, Matson S, Northern I. Maternal group B streptococcal (GBS) genital tract colonization at term in women who have asymptomatic GBS bacteriuria. Infect Dis Obstet Gynecol 2003, 11(4):203-207. 10.1080/10647440300025522, 1852292, 15108866.
22. Meyn LA, Moore DM, Hillier SL, Krohn MA. Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol 2002, 155(10):949-957. 10.1093/aje/155.10.949, 11994235.
23. Paoletti LJ, Bradford J, Paoletti LC. A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts. J Clin Microbiol 1999, 37(11):3759-3760. 85754, 10523595.
24. Shet A, Ferrieri P. Neonatal & maternal group B streptococcal infections: a comprehensive review. Indian J Med Res 2004, 120(3):141-150.
25. Smith JM, Rexroth JA, Chaffin DG, Jackman SH. Serotyping group B streptococci in a small community hospital: an analysis of distribution and site of isolation. Infect Dis Obstet Gynecol 2002, 10(4):165-169. 10.1155/S1064744902000182, 1784619, 12648309.
26. Ferrieri P, Hillier SL, Krohn MA, Moore D, Paoletti LC, Flores AE. Characterization of vaginal & rectal colonization with multiple serotypes of group B streptococci using multiple colony picks. Indian J Med Res 2004, 119(Suppl):208-212.
27. Al-Sweih N, Hammoud M, Al-Shimmiri M, Jamal M, Neil L, Rotimi V. Serotype distribution and mother-to-baby transmission rate of Streptococcus agalactiae among expectant mothers in Kuwait. Arch Gynecol Obstet 2005, 272(2):131-135. 10.1007/s00404-004-0705-z, 15702324.
28. Amin A, Abdulrazzaq YM, Uduman S. Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 2002, 45(1):42-46. 10.1053/jinf.2001.0990, 12217731.
29. Berg S, Trollfors B, Lagergard T, Zackrisson G, Claesson BA. Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect 2000, 6(1):9-13. 10.1046/j.1469-0691.2000.00007.x, 11168030.
30. Brimil N, Barthell E, Heindrichs U, Kuhn M, Lutticken R, Spellerberg B. Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol 2006, 296(1):39-44. 10.1016/j.ijmm.2005.11.001, 16361113.
31. Dhanoa A, Karunakaran R, Puthucheary SD. Serotype distribution and antibiotic susceptibility of group B streptococci in pregnant women. Epidemiol Infect 2009, 1-3.
32. Dore N, Bennett D, Kaliszer M, Cafferkey M, Smyth CJ. Molecular epidemiology of group B streptococci in Ireland: associations between serotype, invasive status and presence of genes encoding putative virulence factors. Epidemiol Infect 2003, 131(2):823-833. 10.1017/S0950268803008847, 2870025, 14596522.
33. Ellis S, Kotiw M, Garland SM. Restriction endonuclease analysis of group B streptococcal isolates from two distinct geographical regions. J Hosp Infect 1996, 33(4):279-287. 10.1016/S0195-6701(96)90014-6, 8864940.
34. Eren A, Kucukercan M, Oguzoglu N, Unal N, Karateke A. The carriage of group B streptococci in Turkish pregnant women and its transmission rate in newborns and serotype distribution. Turk J Pediatr 2005, 47(1):28-33.
35. Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, Orefici G, Dicuonzo G, Creti R. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol 2007, 45(9):2909-2916. 10.1128/JCM.00999-07, 2045288, 17634303.
36. Gonzalez Pedraza Aviles A, Ortiz Zaragoza MC, Mota Vazquez R. Serotypes and antimicrobial susceptibility of group B Streptococcus from pregnant women in Mexico. Rev Latinoam Microbiol 2002, 44(3-4):133-136.
37. Grimwood K, Stone PR, Gosling IA, Green R, Darlow BA, Lennon DR, Martin DR. Late antenatal carriage of group B Streptococcus by New Zealand women. Aust N Z J Obstet Gynaecol 2002, 42(2):182-186. 10.1111/j.0004-8666.2002.00182.x, 12069147.
38. Hakansson S, Axemo P, Bremme K, Bryngelsson AL, Wallin MC, Ekstrom CM, Granlund M, Jacobsson B, Kallen K, Spetz E, Tessin I, . Swedish Working Group for the Prevention of Perinatal Group B Streptococcal Infections Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. Acta Obstet Gynecol Scand 2008, 87(1):50-58. 10.1080/00016340701802888, 18158627, Swedish Working Group for the Prevention of Perinatal Group B Streptococcal Infections.
39. Jones N, Oliver K, Jones Y, Haines A, Crook D. Carriage of group B streptococcus in pregnant women from Oxford, UK. J Clin Pathol 2006, 59(4):363-366. 10.1136/jcp.2005.029058, 1860374, 16473927.
40. Kieran E, Matheson M, Mann AG, Efstratiou AA, Butler K, Gorman W. Group B streptococcus (GBS) colonisation among expectant Irish mothers. Ir Med J 1998, 91(1):21-22.
41. Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, Paoletti LC, Ferrieri P, Madoff LC. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999, 179(4):1030-1033. 10.1086/314666, 10068604.
42. Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, Oh KY, Yoon HR, Pai SY, Foxman B, Ki M. Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect 2010, 138(2):292-298. 10.1017/S0950268809990859, 19781117.
43. Marchaim D, Hallak M, Gortzak-Uzan L, Peled N, Riesenberg K, Schlaeffer F. Risk factors for carriage of group B streptococcus in southern Israel. Isr Med Assoc J 2003, 5(9):646-648.
44. Martins ER, Pessanha MA, Ramirez M, Melo-Cristino J. Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol 2007, 45(10):3224-3229. 10.1128/JCM.01182-07, 2045366, 17699641.
45. Matsubara K, Katayama K, Baba K, Nigami H, Harigaya H, Sugiyama M. Seroepidemiologic studies of serotype VIII group B Streptococcus in Japan. J Infect Dis 2002, 186(6):855-858. 10.1086/342411, 12198624.
46. Motlova J, Strakova L, Urbaskova P, Sak P, Sever T. Vaginal & rectal carriage of Streptococcus agalactiae in the Czech Republic: incidence, serotypes distribution & susceptibility to antibiotics. Indian J Med Res 2004, 119(Suppl):84-87.
47. Moyo SR, Maeland JA, Bergh K. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe. J Med Microbiol 2002, 51(7):595-600.
48. Moyo SR, Mudzori J, Tswana SA, Maeland JA. Prevalence, capsular type distribution, anthropometric and obstetric factors of group B Streptococcus (Streptococcus agalactiae) colonization in pregnancy. Cent Afr J Med 2000, 46(5):115-120.
49. Namavar Jahromi B, Poorarian S, Poorbarfehee S. The prevalence and adverse effects of group B streptococcal colonization during pregnancy. Arch Iran Med 2008, 11(6):654-657.
50. Palacios GC, Gonzalez MN, Beltran M, Arredondo JL, Torres J, Solorzano F. Serotypes of 286 group B streptococci isolated from asymptomatic carriers and invasive disease cases in Mexico. Rev Latinoam Microbiol 2005, 47(1-2):21-24.
51. Savoia D, Gottimer C, Crocilla C, Zucca M. Streptococcus agalactiae in pregnant women: phenotypic and genotypic characters. J Infect 2008, 56(2):120-125. 10.1016/j.jinf.2007.11.007, 18166228.
52. Sensini A, Tissi L, Verducci N, Orofino M, von Hunolstein C, Brunelli B, Mala GL, Perocchi F, Brunelli R, Lauro V, Ferrarese R, Gilardi G. Carriage of group B Streptococcus in pregnant women and newborns: a 2-year study at Perugia General Hospital. Clin Microbiol Infect 1997, 3(3):324-328. 10.1111/j.1469-0691.1997.tb00621.x, 11864128.
53. Seoud M, Nassar AH, Zalloua P, Boghossian N, Ezeddine J, Fakhoury H, Abboud J, Melki I, Araj G, Nacouzi G, Sanyoura M, Yunis K. Prenatal and neonatal Group B Streptococcus screening and serotyping in Lebanon: incidence and implications. Acta Obstet Gynecol Scand 89(3):399-403. 10.3109/00016340903560008, 20199356.
54. Simoes JA, Alves VM, Fracalanzza SE, de Camargo RP, Mathias L, Milanez HM, Brolazo EM. Phenotypical characteristics of group B streptococcus in parturients. Braz J Infect Dis 2007, 11(2):261-266. 10.1590/S1413-86702007000200019, 17625774.
55. Suara RO, Adegbola RA, Mulholland EK, Greenwood BM, Baker CJ. Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns. J Natl Med Assoc 1998, 90(2):109-114. 2608311, 9510625.
56. Terakubo S, Ichiman Y, Takemura H, Yamamoto H, Shimada J, Nakashima H. [Serotypes and antibody levels of group B streptococci in pregnant women]. Kansenshogaku Zasshi 2003, 77(3):121-126.
57. Toresani I, Limansky A, Bogado I, Guardati MC, Viale A, Sutich EG. Phenotypic and genotypic study of Streptococcus agalactiae in vagina of pregnant women in Argentina. Medicina (B Aires) 2001, 61(3):295-300.
58. Tsolia M, Psoma M, Gavrili S, Petrochilou V, Michalas S, Legakis N, Karpathios T. Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clin Microbiol Infect 2003, 9(8):832-838. 10.1046/j.1469-0691.2003.00662.x, 14616704.
59. Uh Y, Kim HY, Jang IH, Hwang GY, Yoon KJ. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Yonsei Med J 2005, 46(4):480-483. 10.3349/ymj.2005.46.4.480, 2815831, 16127771.
60. van der Mee-Marquet N, Jouannet C, Domelier AS, Arnault L, Lartigue MF, Quentin R. Genetic diversity of Streptococcus agalactiae strains and density of vaginal carriage. J Med Microbiol 2009, 58(Pt 2):169-173. 10.1099/jmm.0.005827-0, 19141732.
61. van Elzakker E, Yahiaoui R, Visser C, Oostvogel P, Muller A, Ho YR, Wu JJ, van Belkum A. Epidemiology of and prenatal molecular distinction between invasive and colonizing group B streptococci in The Netherlands and Taiwan. Eur J Clin Microbiol Infect Dis 2009, 28(8):921-928. 10.1007/s10096-009-0726-4, 2723670, 19333631.
62. Villasenor Sierra A, Morales Velazquez P, Palacios Saucedo G, Solorzano Santos F. [Prevalence of Streptococcus algalactiae serotype III in pregnant women]. Ginecol Obstet Mex 2004, 72:103-108.
63. von Both U, John A, Fluegge K, Siedler A, Berner R. Molecular epidemiology of invasive neonatal Streptococcus agalactiae isolates in Germany. Pediatr Infect Dis J 2008, 27(10):903-906. 10.1097/INF.0b013e318178d1ff, 18756182.
64. Walsh JA, Hutchins S. Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines. Pediatr Infect Dis J 1989, 8(5):271-277.
65. Elliott JA, Thompson TA, Facklam RR, Slotved HC. Increased sensitivity of a latex agglutination method for serotyping group B streptococcus. J Clin Microbiol 2004, 42(8):3907. 10.1128/JCM.42.8.3907.2004, 497622, 15297565.
66. Ferrieri P, Flores AE. Surface protein expression in group B streptococcal invasive isolates. Adv Exp Med Biol 1997, 418:635-637.
67. Ramaswamy SV, Ferrieri P, Madoff LC, Flores AE, Kumar N, Tettelin H, Paoletti LC. Identification of novel cps locus polymorphisms in nontypable group B Streptococcus. J Med Microbiol 2006, 55(Pt 6):775-783. 10.1099/jmm.0.46253-0, 16687599.
68. Slotved HC, Sauer S, Konradsen HB. False-negative results in typing of group B streptococci by the standard lancefield antigen extraction method. J Clin Microbiol 2002, 40(5):1882-1883. 10.1128/JCM.40.5.1882-1883.2002, 130958, 11980985.
69. Sellin M, Olofsson C, Hakansson S, Norgren M. Genotyping of the capsule gene cluster (cps) in nontypeable group B streptococci reveals two major cps allelic variants of serotypes III and VII. J Clin Microbiol 2000, 38(9):3420-3428. 87398, 10970395.
70. Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels MR, Rubens CE. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun 2005, 73(5):3096-3103. 10.1128/IAI.73.5.3096-3103.2005, 1087335, 15845517.
71. Harrison LH, Elliott JA, Dwyer DM, Libonati JP, Ferrieri P, Billmann L, Schuchat A. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 1998, 177(4):998-1002.
72. Diedrick MJ, Flores AE, Hillier SL, Creti R, Ferrieri P. Clonal Analysis of Colonizing Group B Streptococcus, Serotype IV, a Potential Emerging Pathogen in the United States. J Clin Microbiol 2010,
73. Puopolo KM, Madoff LC. Type IV neonatal early-onset group B streptococcal disease in a United States hospital. J Clin Microbiol 2007, 45(4):1360-1362. 10.1128/JCM.02487-06, 1865845, 17267636.
74. Mavenyengwa RT, Afset JE, Schei B, Berg S, Caspersen T, Bergseng H, Moyo SR. Group B Streptococcus colonization during pregnancy and maternal-fetal transmission in Zimbabwe. Acta Obstet Gynecol Scand 89(2):250-255. 10.3109/00016340903398029, 19916889.
75. Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand 2008, 87(3):260-271. 10.1080/00016340801908759, 18307064.
76. Evans JJ, Klesius PH, Pasnik DJ, Bohnsack JF. Human Streptococcus agalactiae isolate in Nile tilapia (Oreochromis niloticus). Emerg Infect Dis 2009, 15(5):774-776. 10.3201/eid1505.080222, 2687030, 19402966.
77. Foxman B, Gillespie B, Manning SD, Howard LJ, Tallman P, Zhang L, Marrs CF. Incidence and duration of group B Streptococcus by serotype among male and female college students living in a single dormitory. Am J Epidemiol 2006, 163(6):544-551. 10.1093/aje/kwj075, 16421237.
78. Foxman B, Gillespie BW, Manning SD, Marrs CF. Risk factors for group B streptococcal colonization: potential for different transmission systems by capsular type. Ann Epidemiol 2007, 17(11):854-862. 10.1016/j.annepidem.2007.05.014, 2099698, 17689259.
79. Manning SD, Springman AC, Million AD, Milton NR, McNamara SE, Somsel PA, Bartlett P, Davies HD. Association of Group B Streptococcus colonization and bovine exposure: a prospective cross-sectional cohort study. PLoS One 5(1):e8795. 10.1371/journal.pone.0008795, 2808344, 20098699.
80. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A, . Active Bacterial Core Surveillance Team A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002, 347(4):233-239. 10.1056/NEJMoa020205, 12140298, Active Bacterial Core Surveillance Team.
81. Apgar BS, Greenberg G, Yen G. Prevention of group B streptococcal disease in the newborn. Am Fam Physician 2005, 71(5):903-910.
82. Andrews JI, Diekema DJ, Hunter SK, Rhomberg PR, Pfaller MA, Jones RN, Doern GV. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol 2000, 183(4):859-862. 10.1067/mob.2000.108839, 11035326.
83. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001, 45(12):3504-3508. 10.1128/AAC.45.12.3504-3508.2001, 90860, 11709331.
84. Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child 2003, 88(5):375-378. 10.1136/adc.88.5.375, 1719562, 12716700.